Augurex's SPINEstat test for axial spondyloarthritis is a finalist for the ADLM 2026 Disruptive Technology Award

financialpost.com

Augurex's SPINEstat test for axial spondyloarthritis is a finalist for the ADLM 2026 Disruptive Technology Award. The recognition highlights the test's potential to improve early diagnosis of a chronic autoimmune condition often misdiagnosed as back pain, reducing diagnostic delays. Augurex will present SPINEstat at ADLM 2026 in Anaheim, California, from July 27-30, showcasing its leadership in autoimmune diagnostics.


With a significance score of 1.1, this news ranks in the top 53% of today's 30505 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Augurex's SPINEstat test for axial spondyloarthritis is a finalist for the ADLM 2026 Disruptive Technology Award | News Minimalist